Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

EpiCept increases exercise price of June 2010 Warrants to $1.64 per share

EpiCept Corporation has amended the exercise price of its Series A Warrants and Series B Warrants sold in June 2010 from $1.57 per share to $1.64 per share. The exercise price was amended by Amendment No.1 dated as of July 8, 2010, to the Securities Purchase Agreement between EpiCept and each of the purchasers signatory thereto, which amended the Securities Purchase Agreement dated June 25, 2010 between EpiCept and each of the purchasers signatory thereto.

15 Jul 2010

ABR qualifies eDataAudit as Practice Quality Improvement for Maintenance of Certification

D3 Radiation Services announced today that the American Board of Radiology (ABR) has qualified eDataAudit--a new service designed to reduce errors in the delivery of radiation therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of Certification (MOC).

15 Jul 2010

Aeterna Zentaris' partner Keryx receives FDA orphan-drug designation for perifosine in neuroblastoma

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc., has been granted orphan-drug designation by the U.S. Food and Drug Administration for perifosine, Aeterna Zentaris' novel, potentially first-in-class, oral Akt inhibitor, for the treatment of neuroblastoma.

15 Jul 2010

Samsung Medical Center, Pfizer form research partnership

Samsung Medical Center and the world's leading bio-pharmaceutical company Pfizer Inc. announced that they have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles and that may ultimately direct therapies and enhance clinical outcomes in the patients with liver cancer.

14 Jul 2010

Varian adopts Varicent for administering Sales Performance Management needs

Varicent Software Incorporated, the leading innovator in incentive compensation (ICM) and sales performance management (SPM) solutions, announced today that a business unit within Varian Medical Systems, the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions, has selected Varicent for administering its complex sales incentive compensation plans and sales performance management activities.

14 Jul 2010

Health Canada approves FluMist for preventing seasonal influenza

AstraZeneca Canada Inc. announced today that Health Canada has approved FluMist (Influenza Vaccine, Live, Attenuated) for the prevention of seasonal influenza. FluMist is the first vaccine in Canada that is administered as a gentle mist sprayed into the nose.

14 Jul 2010

Telecare management intervention improves pain, depression in cancer patients

Cancer patients receiving care in geographically dispersed urban and rural oncology practices who participated in a program that included telephone-based care management and home-based automated symptom monitoring had greater improvement in pain and depression compared to patients who received usual care, according to a study in the July 14 issue of JAMA.

14 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

New prediction tool estimates risk for recurrence after breast-conserving surgery in DCIS patients

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.

14 Jul 2010

Silence Therapeutics extends ongoing research, development collaboration with AstraZeneca

Silence Therapeutics plc is pleased to announce a one-year extension of its ongoing research and development collaboration with AstraZeneca. Under the terms of the agreement, which has progressed well since being signed in July 2007, Silence and AstraZeneca are jointly collaborating in the identification and optimization of five novel siRNA therapeutic molecules addressing respiratory and oncology indications.

14 Jul 2010

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 Jul 2010

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

Cell Therapeutics today announced that it has signed a manufacturing agreement with NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences S.r.l. for CTI's drug candidate pixantrone.

14 Jul 2010

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced a study showing how the TheraDoc clinical surveillance system helped clinicians at Memorial Hospital Miramar reduce catheter-related infections, which correlated with an increase in infection-control interventions.

14 Jul 2010

New prediction tool may determine patients' risk for ductal carcinoma

14 Jul 2010

HHS grants seek to encourage health care workforce diversity

The Washington Post: "It is a sign of the economic times: Nursing students at Howard University work part-time jobs and still cannot keep up with tuition. … At the start of the month, the game changed. Howard received $1.5 million from the Obama administration to train student nurses and others in sciences such as radiology and occupational therapy.

14 Jul 2010

Evidence-based guidelines could help prevent dangerous radiation overdoses, says MedSolutions

Utilization management programs that use evidence-based guidelines to ensure appropriate use of diagnostic imaging tests could help prevent dangerous radiation overdoses like the one highlighted in a recent New England Journal of Medicine editorial, said MedSolutions, a leading provider of medical management services.

14 Jul 2010

Metamark Genetics closes $22M Series B financing

Metamark Genetics, Inc., a molecular diagnostics company addressing a major challenge in cancer medicine, has completed a $22 million Series B financing. Metamark's Prognosis Determinants platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on pivotal translational and commercialization efforts to bring these breakthrough discoveries to cancer patients worldwide.

14 Jul 2010

ChemGenex agrees with FDA on potential regulatory path to progress OMAPRO for CML

ChemGenex Pharmaceuticals Limited announced today it has agreed with the U.S. Food and Drug Administration (FDA) on a potential regulatory path to progress OMAPRO™ (omacetaxine mepesuccinate) for the treatment of patients with Chronic Myeloid Leukemia (CML).

14 Jul 2010

Fredericksburg Oncology invites participants for new metastatic melanoma clinical trial

Fredericksburg Oncology is now accepting patients for a new clinical trial supported by the National Cancer Institute (NCI) to evaluate treatment for metastatic (advanced stage) melanoma. The current trial, designed at the Mayo Clinic, combines chemotherapy with targeted molecular agents in an effort to improve control of this difficult disease, reports Dr. Frederick C. Tucker, Jr., who heads this practice.

13 Jul 2010

CCO to provide official online scientific analysis of AIDS 2010

Clinical Care Options, a leader in education for healthcare professionals, will provide official online scientific analysis of the XVIII International AIDS Conference in Vienna, Austria, July 18-23, 2010.

13 Jul 2010

Oncology News and Research

Further Reading

EpiCept increases exercise price of June 2010 Warrants to $1.64 per share

ABR qualifies eDataAudit as Practice Quality Improvement for Maintenance of Certification

Aeterna Zentaris' partner Keryx receives FDA orphan-drug designation for perifosine in neuroblastoma

Samsung Medical Center, Pfizer form research partnership

Varian adopts Varicent for administering Sales Performance Management needs

Health Canada approves FluMist for preventing seasonal influenza

Telecare management intervention improves pain, depression in cancer patients

Highlights of AAPM 52nd meeting

New prediction tool estimates risk for recurrence after breast-conserving surgery in DCIS patients

Silence Therapeutics extends ongoing research, development collaboration with AstraZeneca

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

New prediction tool may determine patients' risk for ductal carcinoma

HHS grants seek to encourage health care workforce diversity

Evidence-based guidelines could help prevent dangerous radiation overdoses, says MedSolutions

Metamark Genetics closes $22M Series B financing

ChemGenex agrees with FDA on potential regulatory path to progress OMAPRO for CML

Fredericksburg Oncology invites participants for new metastatic melanoma clinical trial

CCO to provide official online scientific analysis of AIDS 2010

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News